{"id":"https://openalex.org/W2014736718","doi":"https://doi.org/10.1097/00004714-199412000-00003","title":"Is Baseline Agitation a Relative Contraindication for a Selective Serotonin Reuptake Inhibitor","display_name":"Is Baseline Agitation a Relative Contraindication for a Selective Serotonin Reuptake Inhibitor","publication_year":1994,"publication_date":"1994-12-01","ids":{"openalex":"https://openalex.org/W2014736718","doi":"https://doi.org/10.1097/00004714-199412000-00003","mag":"2014736718","pmid":"https://pubmed.ncbi.nlm.nih.gov/7884018"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-199412000-00003","doi":"https://doi.org/10.1097/00004714-199412000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199412000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109214489","display_name":"Gary D. Tollefson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"GARY D. TOLLEFSON","raw_affiliation_strings":["Department of Psychiatry, Ramsey Clinic and Ramsey Foundation, St. Paul, Minnesota","Department of Psychiatry, Ramsey Clinic and Ramsey Foundation, St. Paul, Minnesota; and","Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Ramsey Clinic and Ramsey Foundation, St. Paul, Minnesota","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, Ramsey Clinic and Ramsey Foundation, St. Paul, Minnesota; and","institution_ids":[]},{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064151665","display_name":"John H. Greist","orcid":"https://orcid.org/0000-0002-4712-6132","observed_orcids":["https://orcid.org/0000-0002-4712-6132"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JOHN H. GREIST","raw_affiliation_strings":["Department of Psychiatry, Dean Clinic, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Dean Clinic, Madison, Wisconsin","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103558948","display_name":"James W. Jefferson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JAMES W. JEFFERSON","raw_affiliation_strings":["Department of Psychiatry, Dean Clinic, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Dean Clinic, Madison, Wisconsin","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032744893","display_name":"John H. Heiligenstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JOHN H. HEILIGENSTEIN","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024791837","display_name":"Mary E. Sayler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MARY E. SAYLER","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011597490","display_name":"Sherrie L. Tollefson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SHERRIE L. TOLLEFSON","raw_affiliation_strings":["Department of Psychiatry, Ramsey Clinic and Ramsey Foundation, St. Paul, Minnesota","Department of Psychiatry, Ramsey Clinic and Ramsey Foundation, St. Paul, Minnesota; and","Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Ramsey Clinic and Ramsey Foundation, St. Paul, Minnesota","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, Ramsey Clinic and Ramsey Foundation, St. Paul, Minnesota; and","institution_ids":[]},{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046238435","display_name":"Kenneth A. Kobak","orcid":"https://orcid.org/0000-0002-4075-3045","observed_orcids":["https://orcid.org/0000-0002-4075-3045"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KENNETH KOBACK","raw_affiliation_strings":["Department of Psychiatry, Dean Clinic, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Dean Clinic, Madison, Wisconsin","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1928,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.78147651,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"14","issue":"6","first_page":"385???391","last_page":"385???391"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/agitated-depression","display_name":"agitated depression","score":0.9800000190734863},{"id":"https://openalex.org/keywords/psychomotor-agitation","display_name":"psychomotor agitation","score":0.843999981880188},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.7409999966621399},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":1.0},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9700000286102295},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.8569999933242798},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.5569999814033508},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7350000143051147},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6100000143051147},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.550000011920929},{"id":"https://openalex.org/keywords/risk-benefit-profile","display_name":"risk-benefit profile","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C2776494729","wikidata":"https://www.wikidata.org/wiki/Q1848900","display_name":"Contraindication","level":3,"score":0.9090635180473328},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.8052864074707031},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.656255841255188},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5345163941383362},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.41628721356391907},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.336683452129364},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2446863055229187},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.07034406065940857},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000075202","descriptor_name":"Contraindications","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010552","descriptor_name":"Personality Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010555","descriptor_name":"Personality Inventory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011595","descriptor_name":"Psychomotor Agitation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011595","descriptor_name":"Psychomotor Agitation","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017109","descriptor_name":"Akathisia, Drug-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D017109","descriptor_name":"Akathisia, Drug-Induced","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-199412000-00003","doi":"https://doi.org/10.1097/00004714-199412000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199412000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:7884018","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7884018","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.75,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2004508576","https://openalex.org/W2023249364","https://openalex.org/W2078719282","https://openalex.org/W2009966111","https://openalex.org/W4252421780","https://openalex.org/W1975957737","https://openalex.org/W2152976203","https://openalex.org/W2032399219","https://openalex.org/W1966462376","https://openalex.org/W1996503099"],"abstract_inverted_index":{"A":[0],"common":[1],"presentation":[2],"for":[3,198],"major":[4,160],"depression":[5,21,28,59],"includes":[6],"psychomotor":[7],"agitation.":[8],"However,":[9,102],"this":[10,199],"subtype":[11,162],"has":[12,29],"been":[13,31],"the":[14,24,34,46,141,144,164,175,186,194],"infrequent":[15],"subject":[16],"of":[17,26,95,103,113,120,127,178,185,196],"controlled":[18],"investigation":[19],"during":[20],"trials.":[22],"Yet,":[23],"subcategorization":[25],"agitated":[27,58],"historically":[30],"associated":[32,218],"with":[33,54,159,210],"belief":[35],"that":[36,189],"older,":[37],"sedating":[38],"compounds":[39,70],"have":[40],"a":[41,105,190],"superior":[42,176],"risk:benefit":[43,165],"profile.":[44],"In":[45,155],"8-week,":[47],"double-blind,":[48],"randomized,":[49],"parallel":[50],"trial,":[51],"124":[52],"subjects":[53,122,129,158],"Research":[55],"Diagnostic":[56],"Criteria-compatible":[57],"were":[60],"randomized":[61],"to":[62,72,207,214],"either":[63],"imipramine":[64],"(IMI)":[65],"or":[66],"fluoxetine":[67],"(FLU).":[68],"Both":[69],"proved":[71],"be":[73],"similarly":[74],"effective":[75],"as":[76],"measured":[77],"by":[78,174],"change":[79],"in":[80,92,109,183,212],"HAM-D17,":[81],"HAM-D17":[82,85],"response,":[83],"and":[84,99,217,220],"remission":[86],"rates.":[87],"Similar":[88],"comparability":[89],"was":[90,172],"seen":[91],"secondary":[93],"measures":[94],"agitation,":[96],"anxiety,":[97],"suicidality,":[98],"global":[100],"impressions.":[101],"note,":[104],"statistically":[106],"significant":[107],"difference":[108],"early":[110],"discontinuations":[111],"because":[112],"intolerable":[114],"adverse":[115],"events":[116,139],"emerged.":[117],"Whereas":[118],"43.5%":[119],"IMI":[121,142],"discontinued":[123],"early,":[124],"only":[125],"9.7%":[126],"FLU":[128,145,168],"(p":[130],"<":[131],"0.001)":[132],"did.":[133],"Significantly":[134],"more":[135],"central":[136],"nervous":[137],"system":[138],"characterized":[140],"than":[143],"subgroup":[146],"(IMI,":[147],"24.2%,":[148],"vs.":[149],"FLU,":[150],"6.5%;":[151],"p":[152],"=":[153],"0.006).":[154],"conclusion,":[156],"among":[157],"depression,":[161],"agitated,":[163],"profile":[166],"favored":[167],"over":[169],"IMI.":[170],"This":[171],"driven":[173],"tolerance":[177],"FLU.":[179],"No":[180],"evidence":[181],"emerged":[182],"support":[184],"clinical":[187],"hypothesis":[188],"\"sedating\"":[191],"agent":[192],"is":[193],"treatment":[195],"choice":[197],"group.":[200],"The":[201],"results":[202],"are":[203],"important":[204],"when":[205],"striving":[206],"maximize":[208],"compliance":[209],"pharmacotherapy":[211],"order":[213],"minimize":[215],"recidivism":[216],"psychological":[219],"economic":[221],"morbidity.":[222]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}